Neurona Therapeutics
Phase 3Neurona is developing cell therapies for targeted repair of dysfunctional neural circuits underlying chronic diseases
Founded
2008
Focus
Cell & Gene Therapy
About
Neurona is developing cell therapies for targeted repair of dysfunctional neural circuits underlying chronic diseases
Funding History
3Total raised: $273M
Series C$135MThe Column GroupMay 15, 2021
Series B$106MViking Global InvestorsOct 15, 2018
Series A$32MThe Column GroupAug 15, 2015
Company Info
TypePrivate
Founded2008
LocationSouth San Francisco, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile